Seeing Is Believing
Healthcare - Sector
KROS is currently covered by 7 analysts with an average price target of $27.57. This is a potential upside of $15.57 (129.75%) from yesterday's end of day stock price of $12.
Keros Therapeutics 's activity chart (see below) currently has 75 price targets and 78 ratings on display. The stock rating distribution of KROS is 54.55% BUY and 45.45% HOLD.
Analysts average stock forecasts to be materialized ratio is 42.71% with an average time for these price targets to be met of 79.63 days.
Highest price target for KROS is $27, Lowest price target is $16, average price target is $22.57.
Most recent stock forecast was given by BENJAMIN BURNETT from WELLS FARGO on 05-Mar-2026. First documented stock forecast 04-May-2020.
Currently out of the existing stock ratings of KROS, 6 are a BUY (54.55%), 5 are a HOLD (45.45%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Mar-2026
$20
$9.39 (88.50%)
$23
29 days ago
(05-Mar-2026)
0/2 (0%)
$8.29 (70.79%)
Hold Since 10-Jun-2025
$19
$8.39 (79.08%)
$18
4 months 6 days ago
(28-Nov-2025)
2/2 (100%)
$1.52 (8.70%)
91
Buy Since 31-Jul-2023
$27
$16.39 (154.48%)
$23
4 months 22 days ago
(12-Nov-2025)
0/8 (0%)
$9.53 (54.55%)
Hold Since 17-Jan-2025
$16
$5.39 (50.80%)
$15
4 months 28 days ago
(06-Nov-2025)
4/4 (100%)
$-0.17 (-1.05%)
80
Buy Since 26-Jul-2023
$26
$15.39 (145.05%)
$41
10 months 22 days ago
(12-May-2025)
1/6 (16.67%)
$12.26 (89.23%)
215
What is KROS (Keros Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on KROS (Keros Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on KROS (Keros Therapeutics )?
Which analyst is the currently most bullish on KROS (Keros Therapeutics )?
Which analyst is the currently most reserved on KROS (Keros Therapeutics )?